| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $174.9M | +766.6% |
| SG&A Expense | $97.9M | +138.4% |
| Operating Income | -$354.1M | -445.4% |
| Interest Expense | $30.2M | -6.2% |
| Pre-tax Income | -$516.3M | -251.0% |
| Income Tax | $240K | +7900.0% |
| Net Income | -$516.5M | -251.2% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $505.1M | — |
| Current Assets | $607.3M | — |
| Total Assets | $907.4M | +293.6% |
| Current Liabilities | $293.8M | — |
| Total Liabilities | $339.8M | — |
| Stockholders' Equity | $567.7M | — |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$339.8M | -725.4% |
| Capital Expenditures | $95.7M | — |
| Investing Cash Flow | -$95.7M | -3296.8% |
| Financing Cash Flow | $966.6M | +2524.3% |
| Free Cash Flow | -$435.4M | -942.4% |